Brief: Wuxi Biologics Noted Meeting On, Among Others, Revised Version Of Draft Bill
May 17 (Reuters) - WuXi Biologics (Cayman) Inc
2269.HK :
* NOTED MEETING ON, AMONG OTHERS, REVISED VERSION OF DRAFT
BILL
WAS HELD BY U.S. HOUSE COMMITTEE ON OVERSIGHT AND ACCOUNTABILITY
* CONTENTS OF REVISED DRAFT BILL REMAIN SUBJECT TO FURTHER
REVIEW
AND MODIFICATION AS IT MOVES THROUGH LEGISLATIVE PROCESS
* CO DOES NOT HAVE HUMAN GENOMICS BUSINESS, NOR DOES IT
COLLECT
HUMAN GENOMIC DATA IN ANY OF ITS BUSINESSES
Further company coverage: 2269.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln